Allergy Center at Brookstone
Columbus, Georgia, United States
Medical center in Columbus, Georgia
1220 Brookstone Centre Pkwy, Columbus, GA 31904
About Allergy Center at Brookstone
"The Allergy Center at Brookstone is now part of the AllerVie Health network. AllerVie Health provides the most comprehensive allergy and asthma treatment in Columbus, Georgia. Our board-certified allergists have experience treating a variety of allergies, asthma, and related immunological disorders, which can limit people’s ability to live the lives they love. We put our patients at the center of everything we do and are committed to setting and delivering the gold-standard in allergy and immunology services to those in our care."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Allergy Center at Brookstone
During the past decade, Allergy Center at Brookstone conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas
2004-04-01
2017-05-31
Completed
3,417
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
2001-09-01
2011-12-01
Completed
73
Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
2018-06-18
2024-11-01
Recruiting
120
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Allergy Center at Brookstone
According to Clinical.Site data, the most researched conditions in "Allergy Center at Brookstone" are
"Hereditary Angioedema (HAE)" (2 trials), "Chronic Sinusitis" (1 trials), "Cryopyrin-Associated Periodic Syndromes" (1 trials), "Cryopyrin-associated Periodic Syndromes (CAPS)" (1 trials) and "Familial Cold Autoinflam Syn (FCAS)" (1 trials). Many other conditions were trialed in "Allergy Center at Brookstone" in a lesser frequency.
Clinical Trials Intervention Types at Allergy Center at Brookstone
Most popular intervention types in "Allergy Center at Brookstone" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "ecallantide" (2 trials), "Canakinumab (ACZ885)" (1 trials), "Phosphate Buffer Saline (PBS), pH 7.0" (1 trials) and "SinuNase" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Allergy Center at Brookstone
The vast majority of trials in "Allergy Center at Brookstone" are
5 trials for "All" genders.
Clinical Trials Status at Allergy Center at Brookstone
Currently, there are NaN active trials in "Allergy Center at Brookstone".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Allergy Center at Brookstone,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Allergy Center at Brookstone, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".